Robert Haile to Incidence
This is a "connection" page, showing publications Robert Haile has written about Incidence.
Connection Strength
0.537
-
Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California. PLoS One. 2018; 13(5):e0197146.
Score: 0.028
-
Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012. J Invest Dermatol. 2017 11; 137(11):2282-2290.
Score: 0.026
-
Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer. 2017 06; 108:140-149.
Score: 0.026
-
Childhood cancers in families with and without Lynch syndrome. Fam Cancer. 2015 Dec; 14(4):545-51.
Score: 0.023
-
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology. 2015 Nov; 149(6):1446-53.
Score: 0.023
-
Lynch syndrome and cervical cancer. Int J Cancer. 2015 Dec 01; 137(11):2757-61.
Score: 0.023
-
Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):713-9.
Score: 0.022
-
Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2250-65.
Score: 0.022
-
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst. 2013 Feb 20; 105(4):274-9.
Score: 0.019
-
Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol. 2013 Jun; 20(6):1829-36.
Score: 0.019
-
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
Score: 0.019
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64.
Score: 0.018
-
Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr Cancer. 2012; 64(7):899-910.
Score: 0.018
-
Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut. 2012 Sep; 61(9):1299-305.
Score: 0.018
-
Alcohol intake and colorectal cancer risk by molecularly defined subtypes in a prospective study of older women. Cancer Prev Res (Phila). 2011 Dec; 4(12):2035-43.
Score: 0.017
-
Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
Score: 0.017
-
Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol. 2011 Apr; 117(4):899-905.
Score: 0.017
-
Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010 Dec 01; 127(11):2678-84.
Score: 0.016
-
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010 Jul 21; 102(14):1012-22.
Score: 0.016
-
Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
Score: 0.015
-
Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009 Mar 18; 101(6):432-5.
Score: 0.015
-
Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2625-31.
Score: 0.014
-
Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):2136-45.
Score: 0.014
-
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
Score: 0.014
-
Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008 Jan 09; 299(2):194-201.
Score: 0.013
-
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 06; 297(21):2351-9.
Score: 0.013
-
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst. 2007 Jan 17; 99(2):129-36.
Score: 0.013
-
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul; 129(1):34-41.
Score: 0.011
-
A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma. Clin Colorectal Cancer. 2005 Mar; 4(6):390-5.
Score: 0.011
-
Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):622-9.
Score: 0.009
-
Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):660-3.
Score: 0.009